The application must include: (a) a floor plan locating the laboratory services and the equipment used for containment and for decontamination; (b) details of the closed systems (for example type, number and maximum volume of each); (c) details of the R24 secondary containment (for example the liquid volume the bunding can hold); (d) where the backflow prevention devices on the facility's water supply pipes are, and the results of their testing and commissioning; (e) testing and commissioning results for any biological safety cabinets installed; (f) testing and commissioning results for all decontamination equipment installed, autoclaves included; (g) the proposed method for decontaminating GMO-contaminated process waste, with its details and evidence that it works; (h) details of any R21 assessment of operator exposure to aerosols during closed system work; and (i) if an external LWTS will be used to decontaminate GMOs, (i) its details (for example type, brand and volume), (ii) its testing and commissioning results, (iii) a floor plan showing where it is in relation to the facility, other restricted areas and areas the general public can reach, (iv) a schematic of its pipes, (v) details of its R25(h) secondary containment (for example bund volume) and (vi) the R25(i) contingency plan setting out how spills and failures of the LWTS and its pipes will be handled.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.